Â鶹ŮÓÅ

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • Â鶹ŮÓÅ Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medical Marijuana
  • Medigap Premiums
  • Food Stamp Work Rules
  • Patients in ICE Custody
  • RFK Jr.’s Vaccine Testimony

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Feb 25 2025

Full Issue

Brain 'Pacemaker' To Ease Parkinson's Symptoms Earns FDA Approval

The brain-computer interface technology uses an algorithm to adapt to an individual patient's needs, improving on previous tech that provided constant electrical brain stimulation. Other news includes: antidepressants' effect on dementia; red-light therapy; and more.

The Food and Drug Administration on Monday granted its first approval for a pacemaker-like device for the brain to ease symptoms of Parkinson's disease, which affects nearly 1 million people in the United States. (Goldman, 2/25)

Doctors often use antidepressants to manage the depression, anxiety and agitation that accompanies a diagnosis of dementia. Now, a new study suggests the use of antidepressants may hasten the cognitive decline of people with dementia. It’s a conclusion that some experts consider unwarranted. (LaMotte, 2/24)

Antioxidants that give fruits and flowers their vibrant colors seem to counteract some of the most dangerous reproductive system effects of exposure to microplastics, such as decreased fertility, and could ultimately be used in developing treatments, new peer-reviewed research shows. The paper focused on microplastics’ reproductive toxicity and plant compounds called anthocyanins, which are widely found in nuts, fruits and vegetables. The new review of scientific literature on anthocyanins found that the compounds are probably protective against a range of plastic-induced impacts on hormones, reductions in testosterone and estrogen, decreased sperm counts, lower sperm quality, erectile dysfunction and ovarian damage. (Perkins, 2/24)

A new study published in ACS Food Science & Technology, found that tea leaves naturally adsorb heavy metals, filtering out harmful water contaminants like lead, cadmium or arsenic. The metals become trapped on the surface of the tea leaves and can be removed by simply filtering out the leaves or tossing the tea bag. (Ajasa, 2/25)

Red-light therapy is getting the green light in some health circles, but it’s early yet to say whether that’s a good thing. The treatment, a type of light therapy called photobiomodulation that involves exposing the body to low levels of red or near-infrared light, purports to help users lose weight, look younger and balance mood. It’s popping up everywhere from hotel spas to European beehives. (Janin, 2/24)

There is something you can do that may help you live longer after a colon cancer diagnosis, and you can start it on your own, at your home or a gym. Exercise is associated with longer lives for patients with colon cancer, according to a new study published Monday in Cancer, a journal of the American Cancer Society. (Holcombe, 2/24)

In covid news —

Despite concerns, there was no significant increase in sudden cardiac arrest (SCA) among young athletes during the COVID-19 pandemic, according to national surveillance data. Comparing prepandemic and pandemic periods, the numbers of SCA and sudden cardiac death (SCD) logged in the UNC National Center for Catastrophic Sports Injury Research (NCCSIR) database were not significantly different (203 vs 184, P=0.33), reported Jonathan Drezner, MD, of the University of Washington in Seattle, and colleagues. (Lou, 2/24)

US outpatient prescriptions for hydroxychloroquine and ivermectin, two unproven treatments touted as COVID-19 treatments during the pandemic, doubled and increased by 10-fold, respectively, from January 30, 2020, to June 30, 2023, according to a new study in Health Affairs. The 3 million prescriptions for the drugs resulted in $272 million estimated spending, and older adults were more likely to take these treatments, the study authors said. (Soucheray, 2/24)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 23
  • Wednesday, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 Â鶹ŮÓÅ